URGN · All filings · Read this filing
What changed 10-Q
Item 1. Legal Proceedings
2024-11-06 compared with 2024-08-13 · 2 added, 0 removed, 10 unchanged (17% of the section changed)
4 unchanged sentences
Patent Numbers 9,040,074 and 9,950,069 and seeking a permanent injunction preventing market entry of a generic product from Teva prior to the expiry of such patents.
+Added: The Company stipulated to the dismissal of Teva Pharmaceutical Industries, Ltd.
+Added: without prejudice and the action continues against the other two Teva entities.
Both patents are listed in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) for Jelmyto .
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.